The role of medical and psychosocial factors for unfavourable coronary risk factor control

John Munkhaugen1, Elise Sverre1, Kari Peersen2

  • 1a Department of Medicine , Drammen Hospital , Drammen , Norway ;

Insights

This study identifies factors impacting coronary heart disease (CHD) risk control and prognosis. Findings will inform tailored prevention programs for CHD patients.

Area of Science:

  • Cardiology
  • Public Health
  • Behavioral Medicine

Background:

  • Coronary heart disease (CHD) management requires understanding factors influencing risk control and patient prognosis.
  • Identifying socio-demographic, medical, and psychosocial factors is crucial for effective CHD patient care.

Purpose of the Study:

  • To identify socio-demographic, medical, and psychosocial factors associated with coronary risk control and prognosis in CHD patients.
  • To assess the impact of these factors on CHD outcomes in a representative patient sample.

Main Methods:

  • A two-phase study involving a cross-sectional analysis of patient data (hospital records, questionnaires, clinical exams, blood samples).
  • Prospective follow-up to explore the independent effects of identified factors on subsequent coronary events, controlling for baseline risks.
  • Phase II will test tailored interventions targeting modifiable factors identified in Phase I.

Main Results:

  • 1366 CHD patients (21% women, aged 18-80) with events 17 months prior were studied (83% participation).
  • Data from hospital records were also obtained for non-participants.

Conclusions:

  • The identified study factors may significantly influence CHD risk factors and patient prognosis.
  • This research can guide the development of personalized prevention programs addressing patient needs and behaviors.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
851
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
460
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
665
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
410